Most Popular Stories
- DNA sequencing exposes new uses for Pfizer targeted cancer drugs
- Preclinical study triggers 'massive response' from desperate Alzheimer's patients
- Hungry Valeant snags Eyetech in ongoing buyout spree
- Chelsea shares nosedive on FDA's questions about key drug
- GSK studies Chinese remedies to discover new drugs
- What's next for Stryker after MacMillan's exit?
- GSK studies Chinese remedies to discover new drugs
- Chelsea shares nosedive on FDA's questions about key drug
- DNA sequencing exposes new uses for Pfizer targeted cancer drugs
- Preclinical study triggers 'massive response' from desperate Alzheimer's patients
- Hungry Valeant snags Eyetech in ongoing buyout spree
Webinars
- Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series) Increasingly, new technologies are making it possible to carefully identify sets of patien
- Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected DevicesAfter launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
Featured Jobs
-
Clinical Research Associate
Jennerex, Inc - San Francisco, CA -
District Sales Manager – Hematology, Denver / Phoenix Job
Celgene Corporation - Denver, CO, US -
Benefits Specialist Job
Celgene Corporation - Summit, NJ, US -
Program Lead - Scientific Information Architecture & Search
Merck - Kenilworth, NJ -
Director Marketing Communications
Bailey Search & Associates - Boston, MA
Events
- CALBIO2012: Driven By Patients - Marriott Marquis
March 8-9 — San Francisco, CA - DCAT Week 2012
Mar 12-15 — New York City - World Orphan Drug Congress USA 2012
10-13 April, 2012 — Gaylord National Resort and Convention Center, Washington, D.C. - Just Released: New Trends in Preventive and Therapeutic Vaccine
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Failing to Establish and Maintain CAPA Systems? Your Company Could Be At Risk.
- Central Nervous System (CNS) Compound Library from OTAVA
- New MicroMass Study of Social Media Behavior Offers Connection Planning Insights for Healthcare Marketers
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
- The Cutting Edge of Chemistry
- Online Multilingual marketing strategy
FDA Commissioner Andrew von Eschenbach
